Zu‐Jiang Yu

439 total citations
15 papers, 184 citations indexed

About

Zu‐Jiang Yu is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Zu‐Jiang Yu has authored 15 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Zu‐Jiang Yu's work include Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). Zu‐Jiang Yu is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). Zu‐Jiang Yu collaborates with scholars based in China, United States and Switzerland. Zu‐Jiang Yu's co-authors include Qing‐Lei Zeng, Hongxia Liang, Zhiqin Li, Dawei Zhang, Jun Lv, Chunxia Li, Yanmin Liu, Guanglin Cui, Wei Li and Fanpu Ji and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Hepatology and Clinical & Experimental Immunology.

In The Last Decade

Zu‐Jiang Yu

14 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zu‐Jiang Yu China	9	111	104	30	27	21	15	184
Montserrat Maldonado‐González Mexico	11	332 3.0×	305 2.9×	34 1.1×	37 1.4×	19 0.9×	26	432
Jiaquan Huang China	9	105 0.9×	86 0.8×	26 0.9×	27 1.0×	31 1.5×	25	198
Daniel Bradshaw United Kingdom	7	62 0.6×	53 0.5×	34 1.1×	15 0.6×	39 1.9×	14	132
Marine Turek France	5	134 1.2×	161 1.5×	16 0.5×	25 0.9×	21 1.0×	6	198
Milotka Fabri Serbia	6	165 1.5×	163 1.6×	48 1.6×	15 0.6×	5 0.2×	27	223
Zunaira Awan Pakistan	10	261 2.4×	277 2.7×	49 1.6×	39 1.4×	22 1.0×	15	343
Waleed K. Al‐Hamoudi Saudi Arabia	11	205 1.8×	151 1.5×	29 1.0×	17 0.6×	17 0.8×	21	244
Shuqin Gu China	6	68 0.6×	44 0.4×	19 0.6×	20 0.7×	67 3.2×	15	172
Ahmed F. Sherief Egypt	7	167 1.5×	165 1.6×	54 1.8×	11 0.4×	8 0.4×	20	246
Silvia Requena Spain	8	94 0.8×	83 0.8×	84 2.8×	36 1.3×	33 1.6×	17	220

Countries citing papers authored by Zu‐Jiang Yu

Since Specialization

Citations

This map shows the geographic impact of Zu‐Jiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu‐Jiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu‐Jiang Yu more than expected).

Fields of papers citing papers by Zu‐Jiang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu‐Jiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu‐Jiang Yu. The network helps show where Zu‐Jiang Yu may publish in the future.

Co-authorship network of co-authors of Zu‐Jiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zu‐Jiang Yu. A scholar is included among the top collaborators of Zu‐Jiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu‐Jiang Yu. Zu‐Jiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Dong, Jianxia, Shan Ren, Ping Wu, et al.. (2025). Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. Hepatology International. 19(6). 1331–1346.

Zeng, Qing‐Lei, et al.. (2024). Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study. BMC Infectious Diseases. 24(1). 830–830. 2 indexed citations

Zeng, Qing‐Lei, Zu‐Jiang Yu, Jun Lv, et al.. (2022). Sofosbuvir‐based therapy for late pregnant women and infants with severe chronic hepatitis C: A case series study. Journal of Medical Virology. 94(9). 4548–4553. 10 indexed citations

Zeng, Qing‐Lei, Zu‐Jiang Yu, Fanpu Ji, et al.. (2021). Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study. BMC Infectious Diseases. 21(1). 10 indexed citations

Zeng, Qing‐Lei, Zu‐Jiang Yu, Fanpu Ji, et al.. (2020). Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study. Clinical Infectious Diseases. 73(9). e3324–e3332. 34 indexed citations

Zeng, Qing‐Lei, Zu‐Jiang Yu, Jia Shang, et al.. (2020). Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels. Open Forum Infectious Diseases. 7(6). ofaa208–ofaa208. 16 indexed citations

Zeng, Qing‐Lei, et al.. (2019). p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma. Cancer Medicine. 9(2). 711–723. 14 indexed citations

Zeng, Qing‐Lei, Ji‐Yuan Zhang, Wei Li, et al.. (2017). Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study. Journal of Hepatology. 66(6). 1123–1129. 37 indexed citations

Li, Zhiqin, Ping Yü, Zu‐Jiang Yu, et al.. (2016). Dynamic changes in CD45RA−Foxp3high regulatory T-cells in chronic hepatitis C patients during antiviral therapy. International Journal of Infectious Diseases. 45. 5–12. 7 indexed citations

10.

Zeng, Qing‐Lei, Xuexiu Zhang, Yan Chen, et al.. (2016). Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study. Gut and Liver. 10(6). 955–961. 6 indexed citations

11.

Li, Juan, Ranran Sun, Zu‐Jiang Yu, et al.. (2015). Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 30(8). 336–341. 9 indexed citations

12.

Li, Jingjing, Zu‐Jiang Yu, Duolu Li, et al.. (2014). Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway. BMC Gastroenterology. 14(1). 151–151. 15 indexed citations

13.

Wang, Zhe, Hongwei Liu, Kunxue Hong, et al.. (2009). Complete Human Immunodeficiency Virus-1 Specific T Lymphocyte Response to Chinese Human Immunodeficiency Virus-1 B/C Chronic Infectors. Biomedical and Environmental Sciences. 22(6). 522–528. 1 indexed citations

14.

Huang, Huimin, Yuan Zhou, Zu‐Jiang Yu, et al.. (2006). Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts. Molecular Immunology. 44(5). 1052–1055. 17 indexed citations

15.

Eberl, Gérard, et al.. (1998). An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells. Clinical & Experimental Immunology. 114(2). 173–178. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact